Court Rules FDA Must Grant Orphan Drug Exclusivity for Bendeka

Drug Industry Daily
A A
In a second successful legal challenge of the FDA’s approach to orphan drug designations, a federal court ordered the agency to grant Eagle Pharmaceuticals orphan drug exclusivity for its cancer drug Bendeka.

To View This Article:

Login

Subscribe To Drug Industry Daily